Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids

BBA Clinical

Volumn 4, Issue , 2015, Pages 92-98

  Kurano, Makoto ^a,b   Dohi, Tomotaka ^c   Nojiri, Takahiro ^d   Kobayashi, Tamaki ^d   Hirowatari, Yuji ^e,f   Inoue, Asuka ^b,g   Kano, Kuniyuki ^b,g   Matsumoto, Hirotaka ^g   Igarashi, Koji ^e   Nishikawa, Masako ^a,b   Miyauchi, Katsumi ^c   Daida, Hiroyuki ^c   Ikeda, Hitoshi ^a,b,d   Aoki, Junken ^b,g   Yatomi, Yutaka ^a,b,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^e TOSOH CORPORATION   (Japan)

^f SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^g TOHOKU UNIVERSITY   (Japan)

Author keywords

Acute coronary syndrome; Aspirin; Glycero lysophospholipids; Lysophosphatidylserine; Serotonin

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERO LYSOPHOSPHOLIPID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLGLYCEROL; LYSOPHOSPHATIDYLINOSITOL; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; STABLE ANGINA PECTORIS; THROMBOCYTE ACTIVATION;

EID: 84940742241     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2015.08.003     Document Type: Article

References (40)

1. Makide K., Kitamura H., Sato Y., Okutani M., Aoki J. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins Other Lipid Mediat. 2009, 89:135-139.
2. Grzelczyk A., Gendaszewska-Darmach E. Novel bioactive glycerol-based lysophospholipids: new data - new insight into their function. Biochimie 2013, 95:667-679.
3. Makide K., Uwamizu A., Shinjo Y., Ishiguro J., Okutani M., Inoue A., Aoki J. Novel lysophosphoplipid receptors: their structure and function. J. Lipid Res. 2014, 55:1986-1995.
4. Kihara Y., Mizuno H., Chun J. Lysophospholipid receptors in drug discovery. Exp. Cell Res. 2014.
5. Sano T., Baker D., Virag T., Wada A., Yatomi Y., Kobayashi T., Igarashi Y., Tigyi G. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J. Biol. Chem. 2002, 277:21197-21206.
6. Gerrard J.M., Robinson P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta 1989, 1001:282-285.
7. Siess W., Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J. Cell. Biochem. 2004, 92:1086-1094.
8. Haseruck N., Erl W., Pandey D., Tigyi G., Ohlmann P., Ravanat C., Gachet C., Siess W. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2004, 103:2585-2592.
9. Pamuklar Z., Lee J.S., Cheng H.Y., Panchatcharam M., Steinhubl S., Morris A.J., Charnigo R., Smyth S.S. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler. Thromb. Vasc. Biol. 2008, 28:555-561.
10. Yokoyama K., Kudo I., Inoue K. Phospholipid degradation in rat calcium ionophore-activated platelets is catalyzed mainly by two discrete secretory phospholipase As. J. Biochem. 1995, 117:1280-1287.
11. Yokoyama K., Shimizu F., Setaka M. Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography. J. Lipid Res. 2000, 41:142-147.
12. Billah M.M., Lapetina E.G. Formation of lysophosphatidylinositol in platelets stimulated with thrombin or ionophore A23187. J. Biol. Chem. 1982, 257:5196-5200.
13. Kurano M., Suzuki A., Inoue A., Tokuhara Y., Kano K., Matsumoto H., Igarashi K., Ohkawa R., Nakamura K., Dohi T., Miyauchi K., Daida H., Tsukamoto K., Ikeda H., Aoki J., Yatomi Y. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome. Arterioscler. Thromb. Vasc. Biol. 2015, 35:463-470.
14. Figueras J., Domingo E., Cortadellas J., Padilla F., Dorado D.G., Segura R., Galard R., Soler J.S. Comparison of plasma serotonin levels in patients with variant angina pectoris versus healed myocardial infarction. Am. J. Cardiol. 2005, 96:204-207.
15. Yanai H., Hirowatari Y. A significant association of plasma serotonin to cardiovascular risk factors and changes in pulse wave velocity in patients with type 2 diabetes. Int. J. Cardiol. 2012, 157:312-313.
16. Hirowatari Y., Hara K., Shimura Y., Takahashi H. Serotonin levels in platelet-poor plasma and whole blood from healthy subjects: relationship with lipid markers and coronary heart disease risk score. J. Atheroscler. Thromb. 2011, 18:874-882.
17. Dohi T., Miyauchi K., Ohkawa R., Nakamura K., Kishimoto T., Miyazaki T., Nishino A., Nakajima N., Yaginuma K., Tamura H., Kojima T., Yokoyama K., Kurata T., Shimada K., Yatomi Y., Daida H. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. Clin. Chim. Acta 2012, 413:207-212.
18. Okudaira M., Inoue A., Shuto A., Nakanaga K., Kano K., Makide K., Saigusa D., Tomioka Y., Aoki J. Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS. J. Lipid Res. 2014, 55:2178-2192.
19. Hirowatari Y., Hara K., Kamihata H., Iwasaka T., Takahashi H. High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clin. Biochem. 2004, 37:191-197.
20. Ohkawa R., Hirowatari Y., Nakamura K., Ohkubo S., Ikeda H., Okada M., Tozuka M., Nakahara K., Yatomi Y. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clin. Biochem. 2005, 38:1023-1026.
21. Nakamura K., Igarashi K., Ohkawa R., Saiki N., Nagasaki M., Uno K., Hayashi N., Sawada T., Syukuya K., Yokota H., Arai H., Ikeda H., Aoki J., Yatomi Y. A novel enzyme immunoassay for the determination of phosphatidylserine-specific phospholipase A(1) in human serum samples. Clin. Chim. Acta 2010, 411:1090-1094.
22. Sato T., Aoki J., Nagai Y., Dohmae N., Takio K., Doi T., Arai H., Inoue K. Serine phospholipid-specific phospholipase A that is secreted from activated platelets A new member of the lipase family. J. Biol. Chem 1997, 272:2192-2198.
23. Aoki J., Nagai Y., Hosono H., Inoue K., Arai H. Structure and function of phosphatidylserine-specific phospholipase A1. Biochim. Biophys. Acta 2002, 1582:26-32.
24. Morrell C.N., Aggrey A.A., Chapman L.M., Modjeski K.L. Emerging roles for platelets as immune and inflammatory cells. Blood 2014, 123:2759-2767.
25. von Hundelshausen P., Schmitt M.M. Platelets and their chemokines in atherosclerosis-clinical applications. Front. Physiol. 2014, 5:294.
26. Spector A.A. Plaque rupture, lysophosphatidic acid, and thrombosis. Circulation 2003, 108:641-643.
27. + mobilization by phorbol myristate acetate. Biochem. J. 1986, 238:193-199.
28. Crowley S.T., Dempsey E.C., Horwitz K.B., Horwitz L.D. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation 1994, 90:1908-1918.
29. Tsai T.H., Tsai W.J., Chen C.F. Aspirin inhibits collagen-induced platelet serotonin release, as measured by microbore high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B Biomed. Appl. 1995, 669:404-407.
30. Yeung T., Gilbert G.E., Shi J., Silvius J., Kapus A., Grinstein S. Membrane phosphatidylserine regulates surface charge and protein localization. Science 2008, 319:210-213.
31. Leventis P.A., Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 2010, 39:407-427.
32. Tan X., Shi J., Fu Y., Gao C., Yang X., Li J., Wang W., Hou J., Li H., Zhou J. Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation. Thromb. Haemost. 2013, 109:1025-1032.
33. Freyssinet J.M., Toti F. Formation of procoagulant microparticles and properties. Thromb. Res. 2010, 125(Suppl. 1):S46-S48.
34. Nishikawa M., Kurano M., Ikeda H., Aoki J., Yatomi Y. Lysophosphatidylserine has bilateral effects on macrophages in the pathogenesis of atherosclerosis. J. Atheroscler. Thromb. 2015, 22:518-526.
35. Martin T.W., Lagunoff D. Interactions of lysophospholipids and mast cells. Nature 1979, 279:250-252.
36. Smith G.A., Hesketh T.R., Plumb R.W., Metcalfe J.C. The exogenous lipid requirement for histamine release from rat peritoneal mast cells stimulated by concanavalin A. FEBS Lett. 1979, 105:58-62.
37. Bellini F., Bruni A. Role of a serum phospholipase A1 in the phosphatidylserine-induced T cell inhibition. FEBS Lett. 1993, 316:1-4.
38. Frasch S.C., Fernandez-Boyanapalli R.F., Berry K.Z., Leslie C.C., Bonventre J.V., Murphy R.C., Henson P.M., Bratton D.L. Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity. J. Biol. Chem. 2011, 286:12108-12122.
39. Frasch S.C., Fernandez-Boyanapalli R.F., Berry K.A., Murphy R.C., Leslie C.C., Nick J.A., Henson P.M., Bratton D.L. Neutrophils regulate tissue neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine. J. Biol. Chem. 2013, 288:4583-4593.
40. Inoue A., Ishiguro J., Kitamura H., Arima N., Okutani M., Shuto A., Higashiyama S., Ohwada T., Arai H., Makide K., Aoki J. TGFalpha shedding assay: an accurate and versatile method for detecting GPCR activation. Nat. Methods 2012, 9:1021-1029.